Curaleaf, a Massachusetts-based, multistate cannabis operator, is amending the terms of its pending acquisition of Cura Partners because of changing market conditions. Curaleaf, which initially announced the proposed deal in May for an estimated price of almost $1 billion, will now issue 55 million of its shares instead of the original 95.6 million shares in the
Curaleaf amends Cura Partners marijuana deal; antitrust hurdle cleared is a post from: Marijuana Business Daily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs
[Read More ...]
Originally posted on Curaleaf amends Cura Partners marijuana deal; antitrust hurdle cleared via George Scorsis Medical Marijuana News
No comments:
Post a Comment